Link Pharma Chem Reports Positive Financial Performance in Q1 2024

May 29 2024 09:10 PM IST
share
Share Via
Link Pharma Chem, a microcap company in the chemicals industry, has announced its financial results for the quarter ending March 2024. Despite being rated as 'Strong Sell' by MarketsMojo, the company has shown positive performance with its highest operating profit, profit before tax, and profit after tax in the last five quarters.
Link Pharma Chem, a microcap company in the chemicals industry, has recently announced its financial results for the quarter ending March 2024. The results have been declared on May 29, 2024.

According to MarketsMOJO, a leading financial analysis platform, the stock call for Link Pharma Chem is currently 'Strong Sell'. However, the company has shown positive financial performance in the quarter ending March 2024, with a score improvement from -8 to 7 in the last three months.

One of the key factors contributing to this improvement is the company's operating profit (PBDIT) for the quarter, which has been the highest in the last five quarters at Rs 0.92 crore. This indicates a positive trend in the near term for the company's operating profit.

Moreover, Link Pharma Chem has also shown improvement in its operating profit margin, with the highest margin of 11.46% in the last five quarters. This reflects the company's increased efficiency.

In terms of profit before tax (PBT) less other income, the company has achieved its highest figure of Rs 0.48 crore in the last five quarters. The near term trend for PBT is also positive.

Similarly, the company's profit after tax (PAT) for the quarter has been the highest in the last five quarters at Rs 0.26 crore. This indicates a positive trend in the near term for the company's profitability.

Furthermore, Link Pharma Chem has also shown an increase in its earnings per share (EPS) for the quarter, with the highest figure of Rs 0.59 in the last five quarters. This indicates that the company has created higher earnings for its shareholders.

Overall, Link Pharma Chem has shown positive financial performance in the quarter ending March 2024, with improvements in key financial indicators. This reflects the company's efforts towards growth and profitability.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read